A federal judge has cleared the way for Zantac cancer lawsuits to proceed after rejecting an effort by defendants to have all the claims against them dismissed.…
Two new FDA studies raise questions about previous claims Zantac converts into a cancer-causing chemical in the human body.…
Pfizer has halted distribution of Chantix due to the potential presence of high levels of NDMA or other nitrosamines which could increase the risk of cancer.…
The first Zantac bellwether trial is expected to go before juries sometime in mid-2023, according to a schedule issued by the federal judge overseeing the consolidated litigation.…
Attorneys have been appointed to leadership positions in Zantac lawsuits consolidated in California state court.…
A federal judge is prepared to hear arguments over whether Zantac lawsuits filed over NDMA contamination and cancer claims can move forward on June 3 and 4.…
Plaintiffs say Zantac manufacturers have destroyed evidence and intentionally delayed the discovery process for ongoing federal litigation in violation of court orders.…
This week, Sanofi announced intentions to re-launch Zantac under the name Zantac 360, which will use the active ingredient from Pepcid instead of ranitidine, which has been linked to increased cancer risks.…
A Zantac lawsuit filed by a California woman indicates decades of using the now-recalled heartburn drug led to the development of breast cancer.…
A new study links Zantac use, particularly long-term use, with an increased risk of bladder cancer.…
